öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÁõ·ï±ó
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º252

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º211µÚÒ»ÁÙ´²Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
¿Æѧѧλ£ºÒ½Ñ§²©Ê¿
Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
¿Æѧѧλ£ºÒ½Ñ§²©Ê¿ [ÊÕÆð]




¸öÈ˼òÊö :
2017ÄêÈÙ»ñ¡°¹ã¶«Ê¡ÃûÖÐÒ½¡±³ÆºÅ
2015ÄêÈÙ»ñ¡°¹úÎñÔºÕþ¸®ÌØÊâ½òÌùר¼Ò¡±
2014ÄêÈÙ»ñ¹ã¶«¸ßУ¡°¡®Ç§°ÙÊ®È˲Ź¤³Ì¡¯¹ú¼Ò¼¶ÅàÑø¶ÔÏó¡±
2013ÄêÈÙ»ñ¡°¹ú¼ÒÓÐÍ»³ö¹±Ï×µÄÖÐÇàÄêר¼Ò¡±
2013ÄêÈÙ»ñÈËÉ粿¡°¡®°ÙǧÍòÈ˲Ź¤³Ì¡¯¹ú¼Ò¼¶ÅàÑø¶ÔÏó¡±
2011ÄêÈÙ»ñÖлªÖÐҽҩѧ»á¡°¿Æ¼¼Ö®ÐÇ¡±³ÆºÅ
2008ÄêÈÙ»ñÖлªÖÐҽҩѧ»á¡°È«¹ú°ÙÃû½Ü³öÇàÄêÖÐÒ½¡±³ÆºÅ
2003Ä꿹»÷·ÇµäÈÙÁ¢¡°¹ã¶«Ê¡Õþ¸®ÈýµÈ¹¦¡±¡¢¡°¹ãÖÝÊÐÕþ¸®ÏȽø¸öÈ˺ÍÈýµÈ¹¦¡±
¹ã¶«Ê¡±£½¡¾ÖÅú׼Ϊ¡°¹ã¶«Ê¡Î¯±£½¡×¨¼Ò¡±
µÚÒ»½ìÑò³ÇºÃÒ½Éú
¡°ÖÐÒ½ÎåÔàÏà¹ØÀíÂÛ»ù´¡ÓëÓ¦Óᱹ㶫ʡ¿Æѧ¼¼ÊõÒ»µÈ½±£¨ÅÅÃûµÚ¾Å£©£¬2008Äê¡£
¡°ÖÐÒ½ÁÙ´²ÁÆЧÆÀ¼ÛµÄPROÁ¿±íºÍƢθϵÁ¿±íµÄÑо¿¡±¹ã¶«Ê¡¿Æѧ¼¼ÊõÈýµÈ½±£¨ÅÅÃûµÚÒ»£©£¬2009Äê¡£
¡°ÖлªÉú´æÖÊÁ¿Á¿±íµÄÑÐÖƼ°ÆäÓ¦Óá±½ÌÓý²¿¸ßµÈѧУ¿ÆѧÑо¿ÓÅÐã³É¹û½±¿Æ¼¼½ø²½¶þµÈ½±£¨ÅÅÃûµÚÒ»£©£¬2011Äê¡£
¡°ÖлªÉú´æÖÊÁ¿Á¿±íµÄÑÐÖƼ°ÆäÓ¦Óá±ÖлªÖÐҽҩѧ»á¿Æѧ¼¼Êõ½±Àø¶þµÈ½±£¨ÅÅÃûµÚÒ»£©£¬2011Äê¡£
¡°ÖØÖ¢¼¡ÎÞÁ¦PROÁ¿±íµÄÑÐÖƼ°ÆäÓ¦Óá±ÖлªÖÐҽҩѧ»á¿Æѧ¼¼Êõ½±ÀøÈýµÈ½±£¨ÅÅÃûµÚÒ»£©£¬2012Äê¡£
ÖÐÎ÷Ò½½áºÏÄÚ¿Æѧ½Ì²Ä(¸±Ö÷±à)ÖÐÄϵØÇø´óѧ³ö°æÉçÓÅÐã½Ì²ÄÒ»µÈ½±£¨¸±Ö÷±à£©£¬2008Äê¡£
¡¶Éú´æÖÊÁ¿µÄ²â¶¨·½·¨ÓëÓ¦Óá·¹ú¼Òͳ¼Æ¾ÖµÚÎå½ìÈ«¹úͳ¼Æ¿ÆÑÐÓÅÐã³É¹û¶þµÈ½±£¨A2-8£©£¬ÅÅÃûµÚÎ壬2008Äê¡£
¡¶ÊÀ½çÎÀÉú×éÖ¯Éú´æÖÊÁ¿Á¿±íÖйú°æ¡·¹ú¼Ò±ê×¼¾ÖÅú׼ΪÎÀÉú²¿²¿°äÐÐÒµÍƼö±ê×¼£¨³ö°æ·¢ÐУ©¡££¨WS/T119-1999£©1999Äê¡£

¿ÆÑй¤×÷ :
ѧÊõ¼æÖ°
ÖлªÖÐҽҩѧ»áƢθ²¡·Ö»á¸±Ö÷ÈÎίԱ£»
ÊÀ½çÖÐҽҩѧ»áÁªºÏ»áƢθÏû»¯²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á³£ÎñÀíÊ£»
ÊÀ½ç»ªÈËÉú´æÖÊÁ¿Ñо¿»á¸±Ö÷ÈÎίԱ£»
ÖйúÃñ×åҽҩѧ»áƢθ²¡·Ö»á¸±»á³¤
ÊÀ½çÖÐҽҩѧ»áÁªºÏ»á¹úÒ½ÌùÝÉçÇø·þÎñöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±»á³¤
¹ã¶«Ê¡ÖÐҽҩѧ»áÖÐÒ½±ê×¼»¯öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ£»
¹ã¶«Ê¡ÖÐÒ½±ê×¼»¯¼¼ÊõίԱ»áίԱ£»
¹ã¶«Ê¡ÖÐÎ÷Ò½½áºÏѧ»áת»¯Ò½Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ¡£
¹ã¶«Ê¡ÖÐҽҩѧ»áƢθ²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ£»
¹ã¶«Ê¡ÖÐÎ÷Ò½½áºÏѧ»áƢθÏû»¯²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ£»
¿ÆÑÐÏîÄ¿
¹ú¼Ò¼¶¿ÎÌâ10Ï
FGIDsÖÐÒ½Ö¤ºò¶àάÁ¿»¯Õï¶ÏÍøÂçµÄϵͳ½¨Ä£¼°ÁÙ´²ÊµÖ¤Ä£Ê½Ñо¿£¬2018-2021£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð
ÖÐÒ½Ò©ÖÎÁÆÂýÐÔ²¡ÁÙ´²Ñо¿:»ùÓÚ²¡Àí×é֯ѧ¸Ä±äµÄÖÐÒ½Ò©¸ÉÔ¤ÂýÐÔËõÐÔθÑ×µÄÔ¶ÆÚËæ·Ã£¬2015-2019£¬ÖÐÒ½Ò©ÐÐÒµ¿ÆÑÐרÏî·ÖÖÐÐÄ(**-09)
»ùÓÚ¼ÆËã»ú×ÔÊÊÓ¦²âÊÔºÍÌõÄ¿·´Ó¦ÀíÂÛ·ÖÎöµÄFGIDs±æÖ¤Õï¶ÏÄ£Ð͵ķ½·¨Ñ§Ñо¿£¨**£©£¬2014-2017£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð
¶ùͯȺÌåÉçÇø»ñµÃÐÔ·ÎÑ×ÖÐÒ½×ۺϷÀÖη½°¸ÍƹãÓ¦ÓÃÑо¿-ÉçÇø»ñµÃÐÔ·ÎÑ×Á¿±íÉè¼ÆÓë·ÖÎö×Ó¿ÎÌ⣨**£©£¬2014-2015£¬2013ÄêÖÐÒ½Ò©ÐÐÒµ¿ÆÑÐרÏîÏîÄ¿
²¡Ö¤½áºÏÖÎÁƸ¹ÐºÐͳ¦Ò×¼¤×ÛºÏÕ÷µÄÁÙ´²Ê¾·¶ÐÔÑо¿×Ó¿ÎÌ⣨·ÖÖÐÐÄ£©£¨2013BAI02805£©£¬2013-2017£¬2013ÄêÊ®¶þÎå¹ú¼Ò¿Æ¼¼Ö§³Å¼Æ»®¿ÎÌâ
Ƣθϵ¼²²¡»¼Õß½á¾Ö±¨¸æµÄ¼ÆËã»ú×ÔÊÊÓ¦ÊÔÑéÐÅÏ¢ÍøÂçµÄ¹¹½¨Ñо¿£¨**£©£¬2011-2013£¬2010Äê¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿
»ùÓڸβØѪÖ÷ÊèйµÄÔàÏóÀíÂÛÑо¿£º³¦Ò×¼¤×ÛºÏÕ÷´Ó¸ÎÂÛÖεÄ×÷ÓûúÖƼ°Ö¤ÖιæÂÉÑо¿×Ó¿ÎÌ⣨2011CB505100£©£¬2011-2012£¬2010Äê¹ú¼Ò¿Æ¼¼²¿Öصã»ù´¡Ñо¿·¢Õ¹¼Æ»®£¨973¼Æ»®£©
½á¹¹·½³ÌÄ£ÐÍÓëÌõÄ¿·´Ó¦ÀíÂÛÓÃÓÚ»ùÓÚ±æÖ¤µÄ賦¹¦ÄÜÐÔÁ¿±íµÄÑо¿£¨**£©£¬
2009Äê¹ú¼Ò×ÔÈ»»ù½ðÃæÉÏÏîÄ¿
¡°ÒÉÄѲ¡ÖÐÒ½¸ÉÔ¤¼°ÁÆЧÆÀ¼ÛÑо¿¡±£ºÖÐÒ½Ò©ÖÎÁÆÖØÖ¢¼¡ÎÞÁ¦µÄÁÙ´²ÆÀ¼ÛÑо¿£¨2006BAI04A12£©£¬¡°Ê®Ò»Î塱¹ú¼Ò¿Æ¼¼Ö§³Å¼Æ»®ÏîÄ¿¡£
ÖÐÒ½ÁÙ´²ÁÆЧÆÀ¼ÛµÄPROÁ¿±íºÍƢθϵģ¿éµÄÑо¿£¨Åú×¼ºÅ£º**£©£¬04£­06£¬¹ú¼Ò×ÔÈ»»ù½ðÃæÉÏÏîÄ¿

Ê¡²¿¼¶¿ÎÌâ8Ïî»ùÓÚÒÉÄѲ¡µÄµ÷ÀíƢθ·½Ò©×÷ÓûúÖƵĴ´ÐÂÍŶÓ£¬2017-2018£¬¹ã¶«Ê¡½ÌÓýÌü¸ßˮƽ´óѧÍŶÓ×ÊÖúÏîÄ¿
»ùÓÚÍâÃÚÌåmiRNAs¶ÔÂýÐÔήËõÐÔθÑ×»¼ÕßѪÇå·Ö×Ó±ê¼ÇÎïµÄɸѡ¼°½¡Æ¢»¯ðö·¨µÄ¸ÉÔ¤»úÖÆÑо¿£¬2017-2018£¬¹ã¶«Ê¡½ÌÓýÌü¸ßˮƽ´óѧÍŶӴóѧÃæÉÏÏîÄ¿
ÂýÐÔήËõÐÔθÑ×£¬2015-2017£¬¹ã¶«Ê¡ÖÐҽҩǿʡרÏîÓÅÊƲ¡ÖÖÍ»ÆÆÏîÄ¿
ÖÐҽƢθ²¡µÄ¼ÆËã»ú×ÔÊÊÓ¦±æÖ¤Õï¶ÏÄ£ÐÍÑо¿£¬2015-2017£¬¹ã¶«Ê¡²ÆÕþÌü
ÖÐÒ½ÖÎδ²¡±ê×¼ÖÆÐÞ¶©ÏîÄ¿£ºÎ¸Ê³¹Ü·´Á÷²¡ÖÐÒ½Ô¤·À±£½¡£¬2014-2016£¬¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö±ê×¼»¯½¨ÉèÏîÄ¿
¹¦ÄÜÐÔÏû»¯²»Á¼ÕïÁÆÖ¸ÄÏÆÀ¼Û¼°ÐÞ¶©ÏîÄ¿£¬2012-2013£¬2012Äê¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö±ê×¼»¯½¨ÉèÏîÄ¿
¹úÒ½´óʦµËÌúÌνÌÊÚÃûÒ½´«³Ð£ºÕïÖÎƢθ²¡Ñ§Êõ¾­ÑéÑо¿£¬2011-2015£¬2011Äê¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¹úÒ½´óʦµËÌúÌδ«³Ð¹¤×÷ÊÒ½¨ÉèÏîÄ¿
µÂ¶û·Æ·¨ÓÃÓÚƢθϵ¼²²¡Ò½Éú±¨¸æ½á¾ÖµÄÖ¢×´ÌõÄ¿·Ö¼¶Á¿»¯±ê×¼µÄÑо¿£¨2011B**£©£¬2011-2013£¬2011Äê¹ã¶«Ê¡¿Æ¼¼ÁªºÏרÏî
Ö÷ÒªÂÛÎÄ
[1]HongMi,Feng-binLiu*,Hai-wenLi,Jiang-taoHouandPei-wuLi.Anti-inflammatoryeffectofChang-AnShuanonTNBS-inducedexperimentalcolitisinrats.BMCComplementaryandAlternativeMedicine(2017)17:315.(ͨѶ×÷Õߣ¬4Çø£¬SCI,IF:2.288)
[2]HongMi,LindaZhong,TaoHuang,Cheng-yuanLin,LingZhao,Dong-dongHu,Hai-taoXiao,Feng-binLiu*andZhao-xiangBian.Chineseherbalmedicineforulcerativecolitis:asystematicreviewprotocolWorldJTraditChinMed20173(1):xx¨Cxx£»DOI:10.15806/j.issn.2311-8571.2016.0040.(ͨѶ×÷Õߣ¬SCI-e,IF:0.991)
[3]Xin-LinChen,Liang-huanZhong,YiWen,Tian-WenLiu,Xiao-YingLi,Zheng-KunHou,YueHu,Chuan-weiMoandFeng-BinLiu.Inflammatoryboweldisease-specifichealth-relatedqualityoflifeinstruments:asystematicreviewofmeasurementproperties.HealthandQualityofLifeOutcomes(2017)15:177DOI10.1186/s12955-017-0753-2.(ͨѶ×÷Õß,3Çø£¬SCI,IF:2.143)
[4]ChenXL,?ChenZQ,?ZhuSL,LianL,?LiuFB.Prognosticvalueoftransforminggrowthfactor-betainpatientswithcolorectalcancerwhoundergosurgery:ameta-analysis.BMCCancer.?2017Apr417(1):240.doi:10.1186/s12885-017-3215-7.(ͨѶ×÷Õߣ¬2Çø£¬SCI,IF:3.288)
[5]Chao-yuanHuang1,Qian-yiZhou,YueHu,Feng-binLiu,Xin-linChen.Hepatocytegrowthfactorisaprognosticmarkerinpatientswithcolorectalcancer:ameta-analysis.www.impactjournals.com/oncotarget.February21,2017(ͨѶ×÷Õߣ¬1Çø£¬SCI,IF:5.168)
[6]Xin-LinChen,Shi-FengShe,Yu-HuangLi,Kun-HaiZhuang,Yun-BaoPan£¬Feng-BinLiu.Azathioprine/6-mercaptopurineversus5-aminosalicylicfortreatmentofinflammatoryboweldisease.IntJClinExpMed201710(2):1927-1936(ͨѶ×÷Õߣ¬4Çø£¬SCI,IF:1.069)
[7]HuangT,MiH,LinCY,ZhaoL,ZhongLL,LiuFB,ZhangG,LuAP,BianZX*,forMZRWGroup.MOST:most-similarligandbasedapproachtotargetprediction.BMCBioinformatics.2017,18(1):165.£¨µÚÁù×÷Õߣ¬3Çø£¬SCI,2.448)
[8]HOUZheng-kun*,LIUFeng-bin,CHANGXiang,XIENelson.Controversies:thevaluesforhealthinstrumentsofChineseMedicine.ChinJIntegrMed.2017,23(2):146-152.(µÚ¶þ×÷Õߣ¬4Çø£¬SCIE,IF:1.217)
[9]ChenXL,HouJT,YuanY,HuangC,LiuT,MoC,LiH,ChenB,XuQ,HouZK,HeWL,LiuFB*.AdalimumabforModeratelytoSeverelyActiveUlcerativeColitis:ASystematicReviewandMeta-Analysis.BioDrugs.2016,30(3):207-217.(ͨѶ×÷Õߣ¬3Çø£¬SCI,IF:2.809)
[10]ZhaoLN,YuT,LanSY,HouJT,ZhangZZ,WangSS,LiuFB*.Probioticscanimprovetheclinicaloutcomesofhepaticencephalopathy:Anupdatemeta-analysis.ClinResHepatolGastroenterol.2015,39(6):674-682.(ͨѶ×÷Õߣ¬4Çø£¬SCI,2.323)
[11]LIUFeng-bin,JINYong-xing,WUYu-hang,HOUZheng-kun,CHENXin-lin.TranslationandPsychometricEvaluationoftheChineseVersionofFunctionalDigestiveDisordersQualityofLifeQuestionnaire.DigestiveDiseasesandSciences.2014,59(2):390-420.(µÚÒ»×÷Õߣ¬3Çø£¬SCI,IF:2.875)
[12]LiuFB,ChenXL,GuoL,LiuXB.Evaluationofascaleofpatient-reportedoutcomesfortheassessmentofmyastheniagravispatientsinChina.Chinesejournalofintegrativemedicine.201218(10):737-45.(µÚÒ»ºÍͨѶ×÷Õߣ¬SCIE,IF:1.404)
[13]ZhaoLN,YuT,LanSY,HouJT,ZhangZZ,WangSS,LiuFB.Probioticscanimprovetheclinicaloutcomesofhepaticencephalopathy:Anupdatemeta-analysis.ClinResHepatolGastroenterol,201539:674-682.((µÚËÄ×÷Õߣ¬4Çø£¬SCI£¬IF=1.872)
[14]LIUFemg-bin,CHENXin-lin,GUOLi,andLIUXiao-bin.Evaluationofascaleofpatient-reportedoutcomesfortheassessmentofmyastheniagravispatientsinChina.[J].ChineseJournalofIntegrativeMedicine,2012,18(10):737-745..(µÚÒ»×÷Õߣ¬4Çø£¬SCIE,IF:1.059)
[15]LIUFeng-bin#*,HOUZheng-kun#,YANGYun-ying,LIPei-wu,LIQian-wen,NelsonXie,LIJing-wei,ZENGXiang-jing.LiteraturereviewandanalysisoftheapplicationofhealthoutcomeassessmentinstrumentsinChinesemedicine.JIntegrMed.2013,11(3):157-167.(µÚÒ»×÷Õߣ¬4Çø£¬SCIE,IF:1.059)
[16]LIUFeng-bin#*,HOUZheng-kun(#),YANGYun-ying,ZHANGzheng-zheng,XIEDi,NelsonXIE,HongThachNguyen.LiteraturereviewandanalysisofthedevelopmentofhealthoutcomesassessmentinstrumentsinChinesemedicine.JIntegrMed.2013,11(2):80-89.(µÚÒ»×÷Õߣ¬4Çø£¬SCIE,IF:1.059)
[17]HOUZheng-kun,LIUFeng-bin*,FANGJi-qian,LIXiao-ying,LILi-juan,LINChu-hua.AdvisingonPreferredReportingItemsforpatient-reportedoutcomeinstrumentdevelopment:thePRIPROID.ChinJIntegrMed.2013,19(3):172-181.(µÚ¶þ×÷Õߣ¬4Çø£¬SCIE,IF:1.059)
[18]HOUZheng-kun,LIUFeng-bin*,LIXiao-ying,LILi-juan,LINChu-hua.AdvertisingonPreferredReportingItemsforPatient-ReportedOutcomeInstrumentDevelopment:ThePRIPROIDProceedingsof2ndInternationalConferenceonInformationScienceandEngineering(ICISE2010).2010:6434-6439.(ͨѶ×÷Õߣ¬EI)
[19]LVBo,LIUZhi-hui,WANGShu-ping,LIUFeng-bin,YANGXiao-jun,HOUJiang-tao,HOUZheng-kun,CHENBin*.miR-29apromotesintestinalepithelialapoptosisinulcerativecolitisbydown-regulatingMcl-1,InternationalJournalofClinicalandExperimentalPathology,2014,7(12):8542~8552.(µÚËÄ×÷Õߣ¬4Çø£¬SCI1.8908)
[20]LIQian-wen,LIUFeng-bin*,HOUZheng-kun,LUODi.Treatmentofconstipation-predominantirritablebowelsyndromebyfocusingontheliverintermsofTraditionalChineseMedicine:ameta-analysis,JournalofTraditionalChineseMedicine.2013,33(5):562~571.(ͨѶ×÷Õߣ¬4Çø£¬SCI,IF:0.991)
[21]ChenB,SheS,LiD,LiuZ,YangX,ZengZ,LiuF.RoleofmiR-19atargetingTNF-alphainmediatingulcerativecolitis.ScandJGastroenterol,2013,48(7):815-824.(ͨѶ×÷Õߣ¬4Çø£¬SCI,IF:2.3288)
[22]FANGJi-qian*,LIUFeng-bin,HOUZheng-kun.Parallelsubgroupdesignofarandomizedcontrolledclinicaltrial-comparingtheapproachesofChinesemedicineandWesternmedicine.ChinJIntegrMed.2010,16(5):394-398.(µÚ¶þ×÷Õߣ¬4Çø£¬SCIIF:0.578)
[23]LIUFeng-bin*,LILi-juan,HOUZheng-kun,LUORui.ConstructingdataminingmodeloffivevisceracorrelationtheoryofMyastheniaGravisbasedonroughsetandassociationrules.ProceedingsofIEEEInternationalConferenceonBioinformaticsandBiomedicineWorkshops(BIBMW2011).2011:778-783.(µÚÒ»×÷Õߣ¬EI)
[24]HOUZheng-kun*,LIUFeng-bin,LIANGYing-yu,YEQian-yun.TheChineseherbalmedicinalnaturescaleisanimportantbench-to-bedsideapproachformicroscopicresearchofChineseherbs(Abstract).QualityofLifeResearch.2016,25(Suppl1):177.(µÚ¶þ×÷Õߣ¬3Çø£¬SCI,IF:2.344)
[25]HOUZheng-kun*,LIUFeng-bin,CHENXin-lin.Developingthecomputeradaptivetestversionofpatientreportedoutcomesinstrumentforpatientswithfunctionaldyspepsiaandchronicgastritis(Abstract).QualityofLifeResearch.2016,25(Suppl1):106.(µÚ¶þ×÷Õߣ¬3Çø£¬SCI,IF:2.344)
[26]LIUFeng-bin*,LIUXian-hua,HUANGZhong-yu,HOUZheng-kun.Studyonquantitativemethodologyofdiarrheapredominantirritablebowelsyndromebasedonsyndromedifferentiationtheoryandlatentvariablemodel(Abstract),QualityofLifeResearch,2016,25(Suppl1):180.(µÚÒ»×÷Õߣ¬3Çø£¬SCI,IF:2.429)
[27]HOUZheng-kun*,LIUFeng-bin,CHENZhuo-qun.InterpretingtheChineseversionoffunctionaldigestivedisordersqualityoflifequestionnaire(Abstract).QualityofLifeResearch.2015,24(Suppl1):118.(µÚ¶þ×÷Õߣ¬3Çø£¬SCI,IF:2.344)
[28]HOUZheng-kun*,LIUFeng-bin,TANyuan-kun.Improvingthereportingqualityofinstrumentcross-culturaladaption:theIRICAstatement(Abstract).QualityofLifeResearch.2015,24(Suppl1):122.(µÚ¶þ×÷Õߣ¬3Çø£¬SCI,IF:2.344)

InternationalConferencePaper
[29]HOUZheng-kun*,LIUFeng-bin.EducationandCultureforQualityofLifeResearchersinMainlandChina.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.2012:188-189.
[30]LIUFeng-bin*,HOUZheng-kun.ApplicationsofHealth-relatedQualityofLifeAssessmentonChineseMedicineinMainlandChina.PatientReportedOutcomesNewsletter.2010,44:1.
[31]LIUFeng-bin*,HOUZheng-kun,WANGHong-mei.Patient-ReportedOutcomesResearchinChineseMedicine.PatientReportedOutcomesNewsletter.2011,46:6.
[32]LIJing-wei,NguyenHongThach,HOUZheng-kun,LIUFeng-bin*,EvaluationofClinicalEfficacyofChineseMedicineTreatmentofFunctionalDyspepsia.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.Guangzhou:InternationalSocietyforQualityofLifeResearch-AsianChineseChapter(ISOQOL-ACC),2012:190-191.
[33]HOUZheng-kun*,LIUFeng-bin.Evidence-BasedInstrument(EBI):TheComingVibrantFieldinPatient-ReportedOutcomesResearch.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.2012:130-131.
[34]³ÂÐÂÁÖ*,Áõ·ï±ó,ºîÕþÀ¥,ÀîÅàÎä,ׯÀ¥º£,.¶àάÏîÄ¿·´Ó¦ÀíÂÛÓÃÓÚÖØÖ¢¼¡ÎÞÁ¦»¼ÕßPROÁ¿±íµÄÆÀ¼Û.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.Guangzhou:InternationalSocietyforQualityofLifeResearch-AsianChineseChapter(ISOQOL-ACC),2012:142.
[35]ÀîóãÓ±*,Áõ·ï±ó,ºîÕþÀ¥.ÌõÄ¿·´Ó¦ÀíÂÛÓÃÓÚ½¨Á¢Î¸Í´PRO¼ÆËã»ú×ÔÊÊÓ¦ÊÔÑéÌõÄ¿³ØµÄ³õ²½Ñо¿.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.Guangzhou:InternationalSocietyforQualityofLifeResearch-AsianChineseChapter(ISOQOL-ACC),2012:145-155.
[36]ÀîóãÓ±*,Áõ·ï±ó,³ÂÐÂÁÖ,ºîÕþÀ¥.θʹPRO¼ÆËã»ú×ÔÊÊÓ¦ÊÔÑéµÄÃÉÌØ¿¨ÂÞÄ£ÄâºÍ¹¹½¨Ñо¿.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.Guangzhou:InternationalSocietyforQualityofLifeResearch-AsianChineseChapter(ISOQOL-ACC),2012:156-168.
[37]³ÂÐÂÁÖ*,Áõ·ï±ó,ÀîÀö¾ê,ÁÖ³þ»ª,ÀîóãÓ±,ÑîÔÆÓ¢,ÀîÅàÎä,ׯÀ¥º£,ºîÕþÀ¥.Éú´æÖÊÁ¿×ÝÏòöλÔÓéÀÖ¹Ù·½appÏÂÔØȱʧֵ·ÖÎö·½·¨--»ìºÏЧӦģÐͺͶàÖØÌî³ä·¨.Proceedingsof2012AsianChineseQualityofLifeConferenceand5thNationalQualityofLifeConference.Guangzhou:InternationalSocietyforQualityofLifeResearch-AsianChineseChapter(ISOQOL-ACC)